Behavioral Disorders - Opportunities To Shape Future Markets

Over the last decade, behavioral disorders have received increasing attention from the media and medical professionals, but only attention deficit / hyperactivity disorder (ADHD) has emerged as a key market. Including data from the Datamonitor's proprietary Behavioral Disorders Survey 2003, this Market Brief discusses strategies to grow the markets for non-ADHD behavioral disorders.

Scope

Data from Datamonitor’s Behavioral Disorder Survey 2003, which interviewed physicians from the US, Japan, France, Germany, Italy, Spain and the UK 

Analysis of Tourette’s syndrome, conduct disorder, trichotillomania, pathological gambling, kleptomania, and intermittent explosive disorder 

Primary and secondary data are used in an analysis of epidemiological metrics, use of pharmacotherapies and strategies to overcome market barriers 

Report Highlights

A number of issues, such as a lack of robust epidemiology data, low public and physician awareness regarding aetiology, has ensured that significant barriers to entry exist for manufacturers aiming to penetrate non-ADHD behavioral disorder markets.  

Although there are significant barriers to entry, Datamonitor believes that there are opportunities for marketed drugs to penetrate non-ADHD behavioral disorders. These include Lilly’s Straterra and Janssen’s Risperdal, however, each company will have to decide whether to attempt to gain an indication or simply promote off label use. 

Reasons to Purchase

Understand the market barriers and how to minimize these 

Enhance knowledge of treatment strategies for behavioral disorders 

Understand how the behavioral disorder markets can be linked to increase patient potential increase potential revenues 

Publisher: Datamonitor CNS Central Nervous System Reports 

To order go to this URL: http://www.bioportfolio.com/cgi-bin/acatalog/Datamonitor_CNS.html#a107